Marinomed Biotech AG: Successful completion of the sale of the Carragelose business to Unither Pharmaceuticals All requirements for closing the deal, including shareholders’ approval and ending of the ...
18m
OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and 12 months ended December 31, 2024. Highlights from the fourth ...
Disposal/Strategic Company DecisionMarinomed Biotech AG: Successful completion of the sale of the Carragelose business to Unither Pharmaceuticals 28.02.2025 / 10:20 CET/CESTThe issuer is solely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback